Skip to content

GRAIL, Inc. GRAL Market capitalization

Market capitalization at other companies

Abbott logo
AbbottABT
$178.41B-22.5%
Guardant Health logo
Guardant HealthGH
$12.12B+130%
Natera, Inc. logo
Natera, Inc.NTRA
$28.34B+48.3%
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
$8.08B-2.7%
Immunome logo
ImmunomeIMNM
$2.47B+323%
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
$2.14B+93.6%

Other financials

Income statement

See full
Revenue$40.8M+28.1%
Operating income-$135.8M+11.6%
Net income-$93.2M+12.3%
EPS (diluted)-$2.29+26.1%

Balance sheet

See full
Cash & equivalents$76.3M-44.4%
Total debt$51.0M-20.7%
Total equity$2.5B+3.6%
Total assets$2.8B-1.5%

Cash flow

See full
Operating cash flow-$87.0M+8.4%
CapEx$503.0K+711%
Free cash flow-$87.5M+8.0%

Valuation

See full
Enterprise value$2.6B+164%
P/S16.8×+8.6×

Profitability

See full
Operating margin-348.7%-153pp
Net margin-253.2%-115pp
FCF margin-187.2%-60.4pp

Returns & leverage

See full
Return on equity-16.1%
Debt / equity0.0×
Current ratio11.7×+2.0×

Where this comes from

Computed from the period-end share price: $2.12B.

The official record: GRAIL, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about GRAIL, Inc.'s market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GRAIL, Inc.'s market capitalization?
GRAIL, Inc. (GRAL) reported market capitalization of $2.12B in Q1 2026.
How has GRAIL, Inc.'s market capitalization changed year-over-year?
GRAIL, Inc.'s market capitalization increased by 144.9% year-over-year, from $865.68M to $2.12B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.